Actuate Therapeutics Files Registration Statement for Initial Public Offering
CHICAGO and FORT WORTH, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (“Actuate”) announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its …